VivoSeq
Other

Laparoscopic Surgery

0

Pipeline Programs

1

Active Trials

3

Companies Involved

Laparoscopic Surgery is an early-stage landscape with 0 programs across 3 companies. The most active players are Chengdu Brilliant Pharmaceutical Co., Ltd., Pfizer, Levita Magnetics.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

79/100

Attrition Rate

17/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

30

clinical trials

Completed19 · 63%
Unknown status5 · 17%
Terminated4 · 13%
Recruiting1 · 3%
Withdrawn1 · 3%

Trial Activity

30 trials

Dexmedetomidine and Laparoscopic Surgery
Completed··N/A·NCT03172065·60 enrolled
Renal Function During Laparoscopic Surgery
Completed··N/A·NCT01722630·60 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)